S
Srinivas Chamakuri
Researcher at Baylor College of Medicine
Publications - 21
Citations - 316
Srinivas Chamakuri is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Medicine & Piperazine. The author has an hindex of 7, co-authored 16 publications receiving 181 citations. Previous affiliations of Srinivas Chamakuri include University of Hyderabad.
Papers
More filters
Journal ArticleDOI
Small molecule modulators of protein-protein interactions: selected case studies.
Madhu Aeluri,Srinivas Chamakuri,Bhanudas Dasari,Shiva Krishna Reddy Guduru,Ravikumar Jimmidi,Srinivas Jogula,Prabhat Arya +6 more
TL;DR: Protein−Protein Interactions Centered on the Inhibitors of Apoptosis Proteins (IAPs) and Synthetic Small Molecules and their Derivatives, and the Unexpected Discovery of First Bivalent SMAC Mimetic AF.
Journal ArticleDOI
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
Elizabeth A. Bowling,Jarey H. Wang,Fade Gong,William Wu,Nicholas J. Neill,Ik Sun Kim,Siddhartha Tyagi,Mayra Orellana,Sarah J. Kurley,Rocio Dominguez-Vidana,Hsiang-Ching Chung,Tiffany Y.T. Hsu,Julien Dubrulle,Alexander B. Saltzman,Heyuan Li,Jitendra K. Meena,Gino M. Canlas,Srinivas Chamakuri,Swarnima Singh,Lukas M. Simon,Calla M. Olson,Lacey E. Dobrolecki,Michael T. Lewis,Bing Zhang,Ido Golding,Jeffrey M. Rosen,Damian W. Young,Anna Malovannaya,Fabio Stossi,George Miles,Matthew J. Ellis,Lihua Yu,Silvia Buonamici,Charles Y. Lin,Kristen L. Karlin,Xiang Zhang,Thomas F. Westbrook +36 more
TL;DR: It is discovered that mis-spliced RNA itself is a molecular trigger for tumor killing through viral mimicry, indicating that dsRNA-sensing pathways respond to global aberrations of RNA splicing in cancer and provoking the hypothesis that STTs may provide unexplored strategies to activate anti-tumor immune pathways.
Journal ArticleDOI
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M pro inhibitors.
Srinivas Chamakuri,Shuo Lu,Melek N. Ucisik,Kurt M. Bohren,Ying-Chu Chen,Huang-Chi Du,John C. Faver,Ravikumar Jimmidi,Feng Li,J. Li,Pranavanand Nyshadham,Stephen Palmer,Jeroen Pollet,Jeroen Pollet,Xuan Qin,Shannon E. Ronca,Banumathi Sankaran,Kiran L. Sharma,Zhi Tan,Leroy Versteeg,Leroy Versteeg,Zhifeng Yu,Martin M. Matzuk,Timothy Palzkill,Damian W. Young +24 more
TL;DR: In this paper, an affinity-based screen of 4 billion DNA-encoded molecules en masse was used to identify a potent class of virus-specific inhibitors of the SARS-CoV-2 main protease (Mpro).
Journal ArticleDOI
AlCl3-induced (hetero)arylation of thienopyrimidine ring: a new synthesis of 4-substituted thieno[2,3-d]pyrimidines
TL;DR: In this article, a single-step method for the synthesis of 4-(hetero)aryl substituted thieno[2,3-d]pyrimidines was proposed and the molecular structure of a representative compound was established unambiguously by single crystal X-ray diffraction.
Journal ArticleDOI
Oleic acid is an endogenous ligand of TLX/NR2E1 that triggers hippocampal neurogenesis
Prasanna Kandel,Fatih Semerci,Rachana Mishra,William T. Choi,Aleksandar Bajić,Dodge Baluya,Lihua Ma,Kevin Hsinwen Chen,Austin C Cao,Tipwarin Phongmekhin,Nick Matinyan,Alba Jiménez-Panizo,Srinivas Chamakuri,Idris O. Raji,Lyra Chang,Pablo Fuentes-Prior,Kevin R. MacKenzie,Caroline L. Benn,Eva Estébanez-Perpiñá,Koen J. T. Venken,David D. Moore,Damian W. Young,Mirjana Maletic-Savatic +22 more
TL;DR: It is reported that oleic acid is an endogenous, metabolic ligand of TLX and open avenues for future therapeutic modulation ofTLX to counteract cognitive and mental decline in aging and diseases associated with decreased neurogenesis.